Feedback PLC (AIM:FDBK) said it has won two 12-month contracts to provide its flagship Bleepa product across two NHS trusts, for a total of £200,000.
One contract was awarded following a successful pilot and two years of co-development work, which the company said represented the “first full-cycle realisation of its pilot-to-contract business model”.
READ: Feedback raises full-year expectations as Bleepa sales grow
The second represents a contract renewal following the success of an initial one-year contract, at a higher value than the initial contract.
Bleepa is an app that enables medical professionals to communicate and share patient documents safely and securely.
“We are delighted to see the value of Bleepa as a core clinical system recognised through the award of two customer contracts,” said chief executive Tom Oakley.
“Over the last year we have significantly grown the number of Bleepa users and it is good to see this growth recognised in the uplift in contract value achieved. These contracts are early evidence of the success of our 2019 strategic shift."
The shift saw Feedback decide to switch its strategic focus to its Bleepa product line, with a £10mln placing last November designed to fund growth opportunities in the UK and abroad.